JORGE CASTILLO to Alemtuzumab
This is a "connection" page, showing publications JORGE CASTILLO has written about Alemtuzumab.
Connection Strength
0.088
-
Ofatumumab for newly diagnosed and relapsed/refractory chronic lymphocytic leukemia. Expert Rev Anticancer Ther. 2011 Feb; 11(2):151-60.
Score: 0.088
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.